Use of prescription drugs and risk of postoperative red blood cell transfusion in breast cancer patients: a Danish population-based cohort study
Authors:
- Anne Marie L. ThomsenATAnne Marie L. Thomsen
- Alma B. PedersenAPAlma B. Pedersen
- Nickolaj R. KristensenNKNickolaj R. Kristensen
- Bjarne Kuno MøllerBMBjarne Kuno Møller
- Christian ErikstrupCEChristian Erikstrup
- Peer M. ChristiansenPCPeer M. Christiansen
- Mette NørgaardMNMette Nørgaard
- Deirdre Cronin-FentonDCDeirdre Cronin-Fenton
Open Access
- 22 December 2017
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research
- Vol. 19 (1) , 135
Abstract
Several frequently used prescription drugs may affect bleeding risk. We investigated use of aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), selective serotonin reuptake inhibitors (SSRIs), and statins and risk of postoperative red blood cell transfusion in breast cancer patients. Using Danish population-based registries, we identified a cohort of women who underwent surgery for primary breast cancer (n = 22,238) during 2005–2012 and ascertained their use of aspirin, NSAIDs, SSRIs, and statins. For each drug, patients were categorized as users if they filled ≥1 prescription in the 60 days prior to surgery. We calculated the 14-day risk of red blood cell transfusion and relative risks (RRs) with 95% confidence intervals (CIs), comparing users with nonusers for each drug and adjusting for age, cancer stage, and Charlson Comorbidity Index score. In our cohort, 1385 (6.2%) women were aspirin users, 1794 (8.0%) were NSAID users, 1110 (4.9%) were SSRI users, and 2053 (9.1%) were statin users. The overall risk of red blood cell transfusion was 1.3%. The 14-day risk of RBC transfusion was 3.5% among aspirin users versus 1.1% among aspirin nonusers (adjusted RR = 1.9, 95% CI: 1.4–2.7), and 1.8% among SSRI users versus 1.2% among SSRI nonusers (adjusted RR = 1.2, 95% CI: 0.7–1.9). Red blood cell transfusion risk was increased among NSAID users, but not in a sensitivity analysis with a 30-day exposure window. Red blood cell transfusion risk was not increased among SSRI and statin users. Primary breast cancer surgery confers a low risk of RBC transfusion. Still, use of aspirin and possibly NSAIDs, but not SSRIs and statins, is associated with increased red blood cell transfusion. This increased risk is not explained by differences in age, stage, or comorbidity level.Keywords
Funding Information
- Elvira and Rasmus Riisforts Foundation
- Helga og Peter Kornings Fond
- PROCRIN established by Lundbeck Foundation and the Novo Nordisk Foundation
This publication has 42 references indexed in Scilit:
- Lifestyle Profile Among Statin UsersEpidemiology, 2013
- The role of aspirin in post-polypectomy bleeding – a retrospective surveyBMC Gastroenterology, 2012
- Statin Use and Microbleeds in Patients With Spontaneous Intracerebral HemorrhageStroke, 2012
- Postoperative Bleeding Complications after Gastric Cancer Surgery in Patients Receiving Anticoagulation and/or Antiplatelet AgentsAnnals of Surgical Oncology, 2012
- Radical Prostatectomy With Robot-assisted Radical Prostatectomy and Laparoscopic Radical Prostatectomy Under Low-dose Aspirin Does Not Significantly Increase Blood LossUrology, 2012
- Bias in Observational Studies of Prevalent Users: Lessons for Comparative Effectiveness Research From a Meta-Analysis of StatinsAmerican Journal of Epidemiology, 2012
- Effects of Selective Serotonin Reuptake Inhibitors on Platelet FunctionDrugs & Aging, 2011
- Use of selective serotonin reuptake inhibitors and risk of re-operation due to post-surgical bleeding in breast cancer patients: a Danish population-based cohort studyBMC Surgery, 2010
- Antidepressants and Risk of Upper Gastrointestinal BleedingBasic & Clinical Pharmacology & Toxicology, 2006
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987